[go: up one dir, main page]

 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Article Types

Countries / Regions

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Search Results (28,304)

Search Parameters:
Keywords = serum

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
9 pages, 266 KiB  
Article
Incidental Parathyroidectomy After Thyroid Surgery: A Single-Center Study
by Roberta Granata, Antonio Zanghì, Marianna Scribano, Giordana Riccioli, Francesca Privitera, Sandro La Vignera, Rosita Angela Condorelli, Francesco Leonforte, Antonio Mistretta, Aldo Eugenio Calogero and Massimiliano Veroux
Biomedicines 2024, 12(10), 2372; https://doi.org/10.3390/biomedicines12102372 (registering DOI) - 17 Oct 2024
Abstract
Background: Hypoparathyroidism with hypocalcemia is the most frequent complication after thyroid surgery. Many risk factors have been involved in the development of this complication, with conflicting results. Incidental parathyroidectomy (IP) may be a frequent cause of postoperative hypocalcemia. In this study, we have [...] Read more.
Background: Hypoparathyroidism with hypocalcemia is the most frequent complication after thyroid surgery. Many risk factors have been involved in the development of this complication, with conflicting results. Incidental parathyroidectomy (IP) may be a frequent cause of postoperative hypocalcemia. In this study, we have evaluated the risk factors associated with the IP in a single-center cohort of patients undergoing thyroid surgery. Patients and methods: The incidence and the risk factors for IP were evaluated in 799 patients scheduled for surgical treatment for thyroid disease between January 2018 and December 2023. Parathyroid hormone levels and serum calcium levels, together with the histological specimens, were evaluated in all patients. Results: Post-operative temporary hypocalcemia was present in 239 (29.9%) patients. A total of 144 patients (21.9%) had an incidental parathyroidectomy. Younger patients (<40 years) had the highest risk of having an incidental parathyroidectomy (RR 1.53 (95% CI 1.084–2.161), OR 1.72 (95% CI 1.091–2.710), p = 0.014). Moreover, thyroid cancer (RR 1.4 (95 CI 1.114–1.882) OR 1.68 (95% CI 1.145–2.484), p < 0.05) and the neck dissection (RR 1.75 (95% CI 1.409–2.198) OR 2.38 (95% CI 1.644–3.460), p < 0.001) were strongly associated with the risk of incidental parathyroidectomy. Conclusions: Younger female patients with thyroid cancer and neck dissection were at the highest risk of incidental parathyroidectomy. A meticulous surgical dissection, together with imaging methods for the detection of the parathyroid glands, may reduce the incidence of this complication. Full article
(This article belongs to the Special Issue Thyroid Disorders: Current Status and Future Prospects)
15 pages, 4195 KiB  
Article
Down Syndrome in Children: A Primary Immunodeficiency with Immune Dysregulation
by Aleksandra Szczawińska-Popłonyk, Natalia Popłonyk and Karina Awdi
Children 2024, 11(10), 1251; https://doi.org/10.3390/children11101251 (registering DOI) - 17 Oct 2024
Abstract
Background: The multisystemic features of Down syndrome (DS) in children are accompanied by immunodeficiency, making them susceptible to infections and immune dysregulation with autoimmune, allergic, inflammatory, and hematological complications. This study was aimed at a better understanding of the abnormalities within the B [...] Read more.
Background: The multisystemic features of Down syndrome (DS) in children are accompanied by immunodeficiency, making them susceptible to infections and immune dysregulation with autoimmune, allergic, inflammatory, and hematological complications. This study was aimed at a better understanding of the abnormalities within the B and T cell compartments and their correlations with clinical immunophenotypes. Methods: Medical records of 35 DS children were retrospectively reviewed, referring to clinical symptomatology including history of infections, immune dysregulation disorders, and humoral and cellular immune response. Results: While the etiology of respiratory tract infections included typical viral and bacterial pathogens, SARS-CoV2-induced inflammatory disease and syndromic immunodeficiency contributed significantly to the deterioration of the clinical course. Allergic diseases in the form of asthma, allergic rhinitis, and alimentary allergy were the most frequent manifestations of immune dysregulation and were followed by autoimmune disorders, such as Crohn’s disease, celiac disease, autoimmune thyroiditis, and alopecia, as well as inflammatory disorders, balanitis xerotica obliterans and lymphadenopathy, and a hematological disorder of myelopoiesis. Deficiency of serum immunoglobulin levels, reduced numbers of naïve B cells, and non-switched memory B cells along with low naïve T helper cells and significantly reduced regulatory T helper cells were the most prominent immune abnormalities. Conclusions: The loss of naïveté in B and T lymphocyte compartments with a deficiency of regulatory T cells may be underpinning pathomechanisms for the skewed immune response. The clinical immunophenotype in DS is complex and represents syndromic primary immunodeficiency with immune dysregulation. Full article
(This article belongs to the Special Issue Advances in Research on Childhood Immune and Allergic Diseases)
Show Figures

Figure 1

Figure 1
<p>The distribution of serum immunoglobulins G, M, and A in the children studied. The immunoglobulin concentrations expressed in mg/dL in relation to the patients’ ages given in months and to age-matched reference values. Reference minimal and maximal values <span class="html-fig-inline" id="children-11-01251-i001"><img alt="Children 11 01251 i001" src="/children/children-11-01251/article_deploy/html/images/children-11-01251-i001.png"/></span>, patients’ values <span class="html-fig-inline" id="children-11-01251-i002"><img alt="Children 11 01251 i002" src="/children/children-11-01251/article_deploy/html/images/children-11-01251-i002.png"/></span>. The horizontal axis shows patients’ ages (months), and the vertical axis shows patients’ results.</p>
Full article ">Figure 2
<p>The relative counts (percentage of total lymphocytes) and absolute numbers of B cell subpopulations in a group of children with Down syndrome in relation to age-matched reference values. Reference minimal and maximal values <span class="html-fig-inline" id="children-11-01251-i001"><img alt="Children 11 01251 i001" src="/children/children-11-01251/article_deploy/html/images/children-11-01251-i001.png"/></span>, patients’ relative counts (%) <span class="html-fig-inline" id="children-11-01251-i003"><img alt="Children 11 01251 i003" src="/children/children-11-01251/article_deploy/html/images/children-11-01251-i003.png"/></span>, absolute numbers (cc) <span class="html-fig-inline" id="children-11-01251-i004"><img alt="Children 11 01251 i004" src="/children/children-11-01251/article_deploy/html/images/children-11-01251-i004.png"/></span>. The horizontal axis shows patients’ ages (months), and the vertical axis shows patients’ results.</p>
Full article ">Figure 3
<p>The relative counts (percentage of total lymphocytes) and absolute numbers of T CD4+ helper cell subpopulations in a group of children with Down syndrome in relation to age-matched values. The regression curve shows the naïve CD4+CD45RA+ to memory CD4+CD45RO+ T helper cell ratio. Reference minimal and maximal values <span class="html-fig-inline" id="children-11-01251-i001"><img alt="Children 11 01251 i001" src="/children/children-11-01251/article_deploy/html/images/children-11-01251-i001.png"/></span>, patients’ relative counts (%) <span class="html-fig-inline" id="children-11-01251-i003"><img alt="Children 11 01251 i003" src="/children/children-11-01251/article_deploy/html/images/children-11-01251-i003.png"/></span>, absolute numbers (cc) <span class="html-fig-inline" id="children-11-01251-i004"><img alt="Children 11 01251 i004" src="/children/children-11-01251/article_deploy/html/images/children-11-01251-i004.png"/></span>. The horizontal axis shows patients’ ages (months), and the vertical axis shows patients’ results.</p>
Full article ">Figure 4
<p>The relative counts (percentage of total lymphocytes) and absolute numbers of T CD8+ cytotoxic/suppressor cell subpopulations in a group of children with Down syndrome in relation to age-matched values. Reference minimal and maximal values <span class="html-fig-inline" id="children-11-01251-i001"><img alt="Children 11 01251 i001" src="/children/children-11-01251/article_deploy/html/images/children-11-01251-i001.png"/></span>, patients’ relative counts (%) <span class="html-fig-inline" id="children-11-01251-i003"><img alt="Children 11 01251 i003" src="/children/children-11-01251/article_deploy/html/images/children-11-01251-i003.png"/></span>, absolute numbers (cc) <span class="html-fig-inline" id="children-11-01251-i004"><img alt="Children 11 01251 i004" src="/children/children-11-01251/article_deploy/html/images/children-11-01251-i004.png"/></span>. The horizontal axis shows patients’ ages (months), and the vertical axis shows patients’ results.</p>
Full article ">
11 pages, 3451 KiB  
Article
Real-Time 3D Imaging and Inhibition Analysis of Human Serum Amyloid A Aggregations Using Quantum Dots
by Liangquan Shi, Gegentuya Huanood, Shuto Miura, Masahiro Kuragano and Kiyotaka Tokuraku
Int. J. Mol. Sci. 2024, 25(20), 11128; https://doi.org/10.3390/ijms252011128 - 16 Oct 2024
Abstract
Serum amyloid A (SAA) is one of the most important precursor amyloid proteins discovered during the study of amyloidosis, but its underlying aggregation mechanism has not yet been well elucidated. Since SAA aggregation is a key step in the pathogenesis of AA amyloidosis, [...] Read more.
Serum amyloid A (SAA) is one of the most important precursor amyloid proteins discovered during the study of amyloidosis, but its underlying aggregation mechanism has not yet been well elucidated. Since SAA aggregation is a key step in the pathogenesis of AA amyloidosis, amyloid inhibitors can be used as a tool to study its pathogenesis. Previously, we reported a novel microliter-scale high-throughput screening (MSHTS) system for screening amyloid β (Aβ) aggregation inhibitors based on quantum dot (QD) fluorescence imaging technology. In this study, we report the aggregation of human SAA (hSAA) in phosphate-buffered saline, in which we successfully visualized hSAA aggregation by QD using fluorescence microscopy and confocal microscopy. Two-dimensional and three-dimensional image analyses showed that most aggregations were observed at 40 μM hSAA, which was the optimal aggregation concentration in vitro. The accuracy of this finding was verified by a Thioflavin T assay. The transmission electron microscopy results showed that QD uniformly bound to hSAA aggregation. hSAA aggregation inhibitory activity was also evaluated by rosmarinic acid (RA). The results showed that RA, which is a compound with high inhibitory activity against Aβ aggregation, also exhibited high inhibitory activity against 40 μM hSAA. These results indicate that the MSHTS system is an effective tool for visualizing hSAA aggregation and for screening highly active inhibitors. Full article
(This article belongs to the Special Issue Quantum Dots for Biomedical Applications)
Show Figures

Figure 1

Figure 1
<p>A schematic image of the visualization of hSAA aggregation using QDs. Initially, hSAA and unlabeled QD monomers were evenly distributed. To induce aggregation, hSAA and unlabeled QDs were incubated at 37 °C for 24 h. After 24 h of incubation, hSAA nonspecifically bound to unlabeled QDs during the aggregation process.</p>
Full article ">Figure 2
<p>Imaging hSAA aggregation at different concentrations. (<b>A</b>) QDs were incubated with hSAA at different concentrations at 37 °C for 1 week, and images were captured using a fluorescence microscope every 24 h. (<b>B</b>) SD values of different concentrations of hSAA over time were determined using ImageJ software. Data represent mean values, and error bars indicate SDs derived from three separate experiments.</p>
Full article ">Figure 3
<p>Left panel: Three-dimensional images of hSAA aggregation at different concentrations after incubation for 168 h. Middle panel: Cut and enlargement of the 3D images of the same part of the left panel. Right panel) Max intensity projection images from 3D images of hSAA aggregation.</p>
Full article ">Figure 4
<p>ThT assessment and TEM observation of 40 μM hSAA protein aggregation. (<b>A</b>) Fluorescence intensity of each group at 24 h. Data represent mean values, and error bars indicate SDs derived from three separate experiments. (<b>B</b>) Left panel: TEM observation of 40 µM hSAA protein fibrils (with QDs). Right panel: Cut and enlargement of the left panel. The white arrows indicate the QDs. (<b>C</b>) Left panel: TEM observation of 40 µM hSAA protein fibrils (without QDs). Right panel: Cut and enlargement of the left panel.</p>
Full article ">Figure 5
<p>Effect of EtOH concentration on hSAA aggregation and inhibitory effect of RA on hSAA and amyloid β (Aβ) aggregation. (<b>A</b>) Fluorescence images of 40 μM hSAA after treatment with different concentrations of EtOH. (<b>B</b>) The SD values of the fluorescence images of hSAA aggregation at different concentrations of EtOH were measured for 24 h. Data represent mean values and error bars indicate SDs derived from three separate experiments. (<b>C</b>) Fluorescence images of 40 μM hSAA (5% EtOH, 9.6% DMSO in PBS) and 25 μM Aβ (5% EtOH, 2.5% DMSO in PBS) treated with different concentrations of RA. (<b>D</b>) Aggregation inhibition activity of RA on hSAA and Aβ. The SD values of fluorescence images of hSAA and Aβ aggregation were measured after 24 h. At 0%: The SD values of the fluorescence images of hSAA and Aβ of the control groups at 0 h in <a href="#ijms-25-11128-f005" class="html-fig">Figure 5</a>C; 100%: The SD values of the fluorescence images of hSAA and Aβ of the control groups at 24 h in <a href="#ijms-25-11128-f005" class="html-fig">Figure 5</a>C. Data represent mean values, and error bars indicate SDs derived from three separate experiments. *, **, and *** denote 0.01 &lt; <span class="html-italic">p</span> &lt; 0.05, 0.001&lt; <span class="html-italic">p</span> &lt; 0.01, and <span class="html-italic">p</span> &lt; 0.001, respectively, which were determined by Welch’s <span class="html-italic">t</span>-test.</p>
Full article ">
17 pages, 5472 KiB  
Article
The Nephroprotective Effect of Punica granatum Peel Extract on LPS-Induced Acute Kidney Injury
by Sena Sahin Aktura, Kazim Sahin, Levent Tumkaya, Tolga Mercantepe, Atilla Topcu, Esra Pinarbas and Zihni Acar Yazici
Life 2024, 14(10), 1316; https://doi.org/10.3390/life14101316 (registering DOI) - 16 Oct 2024
Abstract
Sepsis is an exaggerated immune response resulting from systemic inflammation, which can damage tissues and organs. Acute kidney injury has been detected in at least one-third of patients with sepsis. Sepsis-associated acute kidney injury increases the risk of a secondary infection. Rapid diagnosis [...] Read more.
Sepsis is an exaggerated immune response resulting from systemic inflammation, which can damage tissues and organs. Acute kidney injury has been detected in at least one-third of patients with sepsis. Sepsis-associated acute kidney injury increases the risk of a secondary infection. Rapid diagnosis and appropriate initiation of antibiotics can significantly reduce mortality and morbidity. However, microorganisms are known to develop resistance to antibiotics. Estimations indicate that the annual casualties caused by microbial resistance will surpass cancer fatalities by 2050. The prevalence of bacterial infections and their growing antibiotic resistance has brought immediate attention to the search for novel treatments. Plant-derived supplements contain numerous bioactive components with therapeutic potential against a variety of conditions, including infections. Punica granatum peel is rich in phenolic compounds. The purpose of this study was to determine the anti-inflammatory and anti-bacterial properties of P. granatum peel extract (PGPE) on lipopolysaccharide (LPS)-induced acute kidney injury. Experimental groups were Control, LPS (10 mg/kg LPS, intraperitoneally), PGPE100, and PGPE300 (100 and 300 mg/mL PGPE via oral gavage, respectively, for 7 days). According to biochemical results, serum blood urea nitrogen (BUN), creatinine (Cr) and C-reactive protein (CRP), kidney tissue thiobarbituric acid reactive substances (TBARS), and reduced glutathione (GSH) levels significantly decreased in the PGPE groups compared to the LPS group. Histopathological and immunohistochemical findings revealed that toll-like receptor 4 (TLR4) level and nuclear factor kappa B (NF-κB) expression increased in the LPS group compared to the Control group. In addition, the anti-Gram-negative activity showed a dose-dependent effect on Acinetobacter baumannii, Escherichia coli, and Pseudomonas aeruginosa with the agar well diffusion method and the minimal inhibitory concentration (MIC). The MIC value was remarkable, especially on A. baumannii. We conclude that PGPE has the potential to generate desirable anti-bacterial and anti-inflammatory effects on LPS-induced acute kidney injury in rats. Full article
(This article belongs to the Special Issue Bioactive Natural Compounds: Therapeutic Insights and Applications)
14 pages, 1787 KiB  
Article
Systemic Innate Immune System Restoration as a Therapeutic Approach for Neurodegenerative Disease: Effects of NP001 on Amyotrophic Lateral Sclerosis (ALS) Progression
by Michael S. McGrath, Rongzhen Zhang, Paige M. Bracci, Ari Azhir and Bruce D. Forrest
Biomedicines 2024, 12(10), 2362; https://doi.org/10.3390/biomedicines12102362 - 16 Oct 2024
Abstract
Background/objective: Amyotrophic lateral sclerosis (ALS) is a diagnosis that incorporates a heterogeneous set of neurodegenerative processes into a single progressive and uniformly fatal disease making the development of a uniformly applicable therapeutic difficult. Recent multinational ALS natural history incidence studies have identified systemic [...] Read more.
Background/objective: Amyotrophic lateral sclerosis (ALS) is a diagnosis that incorporates a heterogeneous set of neurodegenerative processes into a single progressive and uniformly fatal disease making the development of a uniformly applicable therapeutic difficult. Recent multinational ALS natural history incidence studies have identified systemic chronic activation of the innate immune system as a major risk factor for developing ALS. Persistent immune activation in patients with ALS leads to loss of muscle and lowering of serum creatinine. The goal of the current study was to test whether the slowing of nerve and muscle destruction in NP001-treated ALS patients compared with controls in phase 2 studies would lead to extension of survival. Methods: Phase 2 clinical studies with NP001, an intravenously administered form of the innate immune system regulator NaClO2, are now reporting long-term survival benefits for drug recipients vs. placebo controls after only six months of intermittent treatment. As a prodrug, NP001 is converted by macrophages to taurine chloramine, a long-lived regulator of inflammation. We performed a pooled analysis of all patients who had completed the studies in two six-month NP001 phase 2 trials. Changes in respiratory vital capacity and the muscle mass product, creatinine, defined treated patients who, compared to placebo, had up to a year of extended survival. Conclusions: The observed longer survival in ALS patients with the greatest inflammation-associated muscle loss provides further evidence that ALS is a disease of ongoing innate immune dysfunction and that NP001 is a disease-modifying drug with sustained clinical activity. Full article
(This article belongs to the Special Issue Neurodegenerative Diseases: From Mechanisms to Therapeutic Approaches)
Show Figures

Figure 1

Figure 1
<p>Innate immune destruction of the neuromuscular junction (NMJ) leads to loss of muscle and respiratory function and death. (<b>A</b>) The motor neuron axon outgrowths interact with the muscle at the neuromuscular junction (NMJ, red circle) (images licensed from istock). This is the site where inappropriately processed disease-associated proteins such as TDP43 are recognized by the innate immune system and begin the process of motor neuron and muscular dysfunction. (<b>B</b>) Loss of NMJ function leads to muscle loss (images licensed from Shutterstock). In addition, the acute phase reaction consumes muscle as a source of rare amino acids, such as phenylalanine, tryptophan, and tyrosine, turning normal muscle into a wasted sarcopenic muscle. Blood creatinine levels quantify the muscle as a source of APP amino acids, and CRP levels increase. (<b>C</b>) The diaphragm is innervated by the phrenic nerve, an outgrowth of a lower motor neuron (images licensed from Shutterstock). VC measurements indirectly measure the function of the NMJ.</p>
Full article ">Figure 2
<p>NP001 efficacy defined by survival analysis and % VC change in phase 2A and 2B completers. (<b>A</b>) Kaplan–Meier curve of survival probability for patients who received NP001 at a dose of 2 mg/kg compared with placebo in completers. In the completers, the median survival (95% confidence interval (CI)) over the entire follow-up duration was 38.6 months (95% CI: 29.9, 47.8) and 28.4 months (95% CI: 25.4, 40.0) in the 2 mg/kg NP001 (blue) and placebo (red) groups, respectively (log-rank, <span class="html-italic">p</span> = 0.04). Patients treated with NP001 had better survival than those on placebo: hazard ratio (HR) = 0.72 (95% CI: 0.52, 0.99). (<b>B</b>) Kaplan–Meier curve of survival probability for patients who received NP001 at a dose of 2 mg/kg compared with placebo in completers with CRP &gt; 1.13 mg/L at baseline. In the completers with baseline CRP &gt; 1.13 mg/L, the median survival (95% confidence interval (CI)) over the entire follow-up duration was 42.7 months (95% CI: 31.3, 50.9) and 28.4 months (95% CI: 24.4, 40.0) in the 2 mg/kg NP001 (blue) and placebo (red) groups, respectively (log-rank, <span class="html-italic">p</span> = 0.002). Patients treated with NP001 had a significant benefit of survival than those on placebo: hazard ratio (HR) = 0.57 (95% CI: 0.39, 0.82). (<b>C</b>) Change in % of VC from baseline over 6 months in participants on NP001 compared with placebo in completers with high CRP at baseline. Percentage VC change from baseline for participants treated with NP001 (<span class="html-italic">n</span> = 72, blue) is compared with the placebo group (<span class="html-italic">n</span> = 83, red). Bars represent mean of % VC change from baseline ± SEM. Average %VC lost over the 6 months of study: NP001: −9.1% (−1.5% per month); placebo: −12.9% (−2.2% per month). The NP001 treatment arm lost 29% less respiratory function than the placebo arm by the end of the study (Wilcoxon test, <span class="html-italic">p</span> = 0.02).</p>
Full article ">Figure 3
<p>Box and whisker plots depicting the distribution of baseline serum creatinine values for the low creatinine group (baseline creatinine &lt; 71 µM/L for males or &lt;53 µM/L for females) (<span class="html-italic">n</span> = 57, in blue) and the high creatinine group (baseline creatinine ≥ 71 µM/L for males or ≥ 53 µM/L for females) (<span class="html-italic">n</span> = 98, in red). Results show that the median baseline creatinine value was statistically significantly lower in the low creatinine group compared with the high creatinine group (Wilcoxon test, <span class="html-italic">p</span> &lt; 0.0001).</p>
Full article ">Figure 4
<p>NP001 efficacy defined by % VC change by creatinine groups in phase 2A and 2B completers with baseline plasma CRP levels &gt; 1.13 mg/L. (<b>A</b>) Change in % of VC from baseline over 6 months in participants on NP001 compared with placebo in those with low creatinine at baseline in completers with CRP &gt; 1.13 mg/L. Percentage VC change from baseline for participants treated with NP001 (<span class="html-italic">n</span> = 25, blue) compared with the placebo group (<span class="html-italic">n</span> = 32, red). Bars represent mean of % VC change from baseline ± SEM. Average %VC lost over the 6 months of study: NP001: −9.7% (average −1.6% per month); placebo: −18.2% (average −3.0% per month). The NP001 treatment arm lost 46% less respiratory function than the placebo arm by the end of the study (Wilcoxon test, <span class="html-italic">p</span> = 0.02). (<b>B</b>) Percentage change from baseline in VC over 6 months in participants on NP001 compared with placebo in those with high creatinine patients with CRP &gt; 1.13 mg/L at baseline. Mean change from baseline in percent VC for participants treated with NP001 (<span class="html-italic">n</span> = 47, blue) compared with the placebo group (<span class="html-italic">n</span> = 51, red). Bars represent mean of % VC change from baseline ± SEM. There was no significant difference between NP001-treated patients and placebos by the end of the study (NP001 = −8.7% vs. placebo = −9.5%) (Wilcoxon test, <span class="html-italic">p</span> = 0.30).</p>
Full article ">Figure 5
<p>Overall survival by low and high creatinine groups in phase 2A and 2B completers with baseline plasma CRP levels &gt; 1.13 mg/L. (<b>A</b>) Kaplan–Meier curve of survival probability for patients who received NP001 at a dose of 2 mg/kg (blue) compared with placebo (red) in the low creatinine group. The median survival (95% confidence interval (CI)) over the entire follow-up duration among those with low serum creatinine at baseline was 45.5 months (95% CI: 28.5, NA) and 28.4 months (95% CI: 24.1, 40.3) in the 2 mg/kg NP001 and placebo groups, respectively (log-rank, <span class="html-italic">p</span> = 0.005). The associated hazard ratio (HR) was 0.41 (95% CI: 0.22, 0.78). (<b>B</b>) Kaplan–Meier curve of survival probability for patients who received NP001 at a dose of 2 mg/kg compared with placebo in the high creatinine group. The median survival (95% confidence interval (CI)) over the entire follow-up duration was 38.6 months (95% CI: 29.9, 50.9) in the NP001 treatment and 29.3 months (95% CI: 20.8, 44.1) in the placebo group (log-tank, <span class="html-italic">p</span> = 0.17) with the associated HR 0.73 (95% CI: 0.46, 1.1).</p>
Full article ">Figure 6
<p>ALS is a systemic innate immune disease: NP001 resets the self-regulatory cycle in ALS patients, mitigating loss of muscle function (images licensed from BioRender). The innate immune system is balanced between activating inflammatory signals and resolving signals after the process initiating the inflammation has been resolved. (<b>A</b>) Inflammation yields the oxidative molecule HOCl, which is rapidly neutralized within macrophages (MO) by free taurine, creating chloramine (TauCl). TauCl reverses inflammation, and the resulting phagocytic wound healing cell makes factors that shut down inflammation. (<b>B</b>) In ALS, misfolded proteins (MFPs) such as TDP43 are recognized at the neuromuscular junction by cells in the peripheral immune system, causing inflammation. In ALS patients, there is insufficient production of regulatory molecules, allowing inflammation to persist and damaging the NMJ, leading to both neuronal and muscular damage to progress unabated. (<b>C</b>) NP001 is converted by inflammatory cells into HOCl, then TauCl, providing an augmentation to the TauCl pathway. In addition, excess HOCl causes dimerization of alpha-2 macroglobulin (Alpha 2-M), creating a high-affinity clearance structure for misfolded proteins such as TDP43. The dimer releases a preformed TGFB1, a known regulator of NFkB, to enhance the resolution process [<a href="#B22-biomedicines-12-02362" class="html-bibr">22</a>]. Re-establishment of innate immune balance slows the loss of muscle and vital capacity, leading to the prolongation of survival.</p>
Full article ">
16 pages, 2958 KiB  
Article
High-Throughput Luminescence-Based Serum Bactericidal Assay Optimization and Characterization to Assess Human Sera Functionality Against Multiple Shigella flexneri Serotypes
by Valentina Caradonna, Marika Pinto, Renzo Alfini, Carlo Giannelli, Miren Iturriza, Francesca Micoli, Omar Rossi and Francesca Mancini
Int. J. Mol. Sci. 2024, 25(20), 11123; https://doi.org/10.3390/ijms252011123 - 16 Oct 2024
Abstract
Shigellosis represents a significant global health concern particularly affecting children under 5 years in low- and middle-income countries (LMICs) and is associated with stunting and antimicrobial resistance. There is a critical need for an effective vaccine offering broad protection against the different Shigella [...] Read more.
Shigellosis represents a significant global health concern particularly affecting children under 5 years in low- and middle-income countries (LMICs) and is associated with stunting and antimicrobial resistance. There is a critical need for an effective vaccine offering broad protection against the different Shigella serotypes. A correlate of protection has not yet been established but there is a general consensus about the relevant role of anti-O-Antigen-specific IgG and its functionality evaluated by the Serum Bactericidal Assay (SBA). This study aims to characterize a high-throughput luminescence-based SBA (L-SBA) against seven widespread Shigella serotypes. The assay was previously developed and characterized for S. sonnei and S. flexneri 1b, 2a, and 3a and has now been refined and extended to an additional five serotypes (S. flexneri 4a, 5b, 6, X, and Y). The characterization of the assay with human sera confirmed the repeatability, intermediate precision, and linearity of the assays; both homologous and heterologous specificity were verified as well; finally, limit of detection and quantification were established for all assays. Moreover, different sources of baby rabbit complement showed to have no impact on L-SBA output. The results obtained confirm the possibility of extending the L-SBA to multiple Shigella serotypes, thus enabling analysis of the functional response induced by natural exposure to Shigella in epidemiological studies and the ability of candidate vaccines to elicit cross-functional antibodies able to kill a broad panel of prevalent Shigella serotypes in a complement-mediated fashion. Full article
(This article belongs to the Special Issue Vaccine Research and Adjuvant Discovery)
Show Figures

Figure 1

Figure 1
<p>Human standard serum assessed in L-SBA against <span class="html-italic">S. flexneri</span> 4a, 5b, 6, X, and Y using the specified assay conditions. 4PL fitting of luminescence at T180 (measured as CPS, counts per second) vs. log-transformed serum dilution. BRC: baby rabbit complement; LB: Luria Bertani medium; PBS: phosphate-buffered saline.</p>
Full article ">Figure 2
<p>Reverse cumulative distribution plots of SBA titers observed at baseline against the newly retrieved <span class="html-italic">S. flexneri</span> 1b NTCT 5 strain and 3a NCTC9989 (new strains) compared to the previously used strains <span class="html-italic">S. flexneri</span> 1b NCTC5 Stansfield, <span class="html-italic">S. flexneri</span> 3a 6885 and <span class="html-italic">S. flexneri</span> 2a strain (old strains). SBA titers have been obtained analyzing sera from individuals enrolled in the NCT05073003 clinical trial. The blue line represents the assay conducted using the old strains, the red line represents the assay conducted using the new strains.</p>
Full article ">Figure 3
<p>Comparison of bactericidal titers obtained in SBA using Cederlane or Pel-Freez baby rabbit complement for <span class="html-italic">S. flexneri</span> 3a (<b>A</b>) and <span class="html-italic">S. flexneri 1b</span> (<b>B</b>) both at visit 1 (V1) and at visit 4 (V4) and comparison between results obtained for samples at the two tested time points (V4/V1). Ns, <span class="html-italic">p</span> &gt; 0.05; ****, <span class="html-italic">p</span> ≤ 0.0001, Wilcoxon matched-pairs signed rank test.</p>
Full article ">Figure 4
<p>SBA titers (IC50) of standard sera tested in 12 independent replicates. The assay was conducted against the <span class="html-italic">S. flexneri</span> 1b, 3a, 4a, 5b, 6, X, and Y strains. Results from individual repeats by each operator are depicted as circles (for operator 1) and triangles (for operator 2), while results obtained for repeats on different days are color-coded as blue (day 1), green (day 2), and red (day 3). The black line represents the geometric mean of all values.</p>
Full article ">Figure 5
<p>Log(IC50 theoretical) obtained for each sample vs. Log (IC50 experimentally obtained). Single data points are indicated with blue dots. The red solid line represents the linear regression, and the green dashed line represents the regression 95% confidence interval (CI). Data refer to L-SBA conducted against <span class="html-italic">S. flexneri</span> 1b, 3a, 4a, 5b, 6, X, and Y, using human standard sera.</p>
Full article ">Figure 6
<p>IC50 reduction (%) in L-SBA against <span class="html-italic">S. flexneri</span> 1b, 3a, 4a, 5b, 6, X, and Y strains compared to undepleted control samples after incubation with homologous or heterologous competitors. Sf = <span class="html-italic">S. flexneri</span>; Sso = <span class="html-italic">S. sonnei</span>; Stm = <span class="html-italic">S</span>. Typhimurium.</p>
Full article ">
36 pages, 3237 KiB  
Article
Spatial and Bioaccumulation of Heavy Metals in a Sheep-Based Food System: Implications for Human Health
by Florin-Ioan Fechete, Maria Popescu, Sorin-Marian Mârza, Loredana-Elena Olar, Ionel Papuc, Florin-Ioan Beteg, Robert-Cristian Purdoiu, Andrei Răzvan Codea, Caroline-Maria Lăcătuș, Ileana-Rodica Matei, Radu Lăcătuș, Adela Hoble, Ioan Valentin Petrescu-Mag and Florin-Dumitru Bora
Toxics 2024, 12(10), 752; https://doi.org/10.3390/toxics12100752 - 16 Oct 2024
Abstract
Heavy metal contamination in agricultural soils presents serious environmental and health risks. This study assessed the bioaccumulation and spatial distribution of nickel, cadmium, zinc, lead, and copper within a sheep-based food chain in the Baia Mare region, Romania, which includes soil, green grass, [...] Read more.
Heavy metal contamination in agricultural soils presents serious environmental and health risks. This study assessed the bioaccumulation and spatial distribution of nickel, cadmium, zinc, lead, and copper within a sheep-based food chain in the Baia Mare region, Romania, which includes soil, green grass, sheep serum, and dairy products. Using inductively coupled plasma mass spectrometry (ICP-MS), we analyzed the concentrations of these metals and calculated bioconcentration factors (BCFs) to evaluate their transfer through trophic levels. Spatial analysis revealed that copper (up to 2528.20 mg/kg) and zinc (up to 1821.40 mg/kg) exceeded permissible limits, particularly near former mining sites. Elevated lead (807.59 mg/kg) and cadmium (2.94 mg/kg) were observed in industrial areas, while nickel and cobalt showed lower concentrations, but with localized peaks. Zinc was the most abundant metal in grass, while cadmium transferred efficiently to milk and cheese, raising potential health concerns. The results underscore the complex interplay between soil properties, contamination sources, and biological processes in heavy metal accumulation. These findings highlight the importance of continuous monitoring, risk assessment, and mitigation strategies to protect public health from potential exposure through contaminated dairy products. Full article
(This article belongs to the Section Agrochemicals and Food Toxicology)
Show Figures

Figure 1

Figure 1
<p>The spatial distribution of detectable elements in sheep milk and cheese samples; comparing mean concentration across different collection areas.</p>
Full article ">Figure 2
<p>The spatial distribution of detectable elements in sheep serum samples; comparing mean concentration across different collection areas.</p>
Full article ">
16 pages, 1324 KiB  
Article
Association between Serum Fatty Acids Profile and MetScore in Women with Severe Obesity
by Emilly Santos Oliveira, Fabiana Martins Kattah, Glaucia Carielo Lima, Maria Aderuza Horst, Nayra Figueiredo, Gislene Batista Lima, Renata Guimarães Moreira Whitton, Gabriel Inacio de Morais Honorato de Souza, Lila Missae Oyama, Erika Aparecida Silveira and Flávia Campos Corgosinho
Nutrients 2024, 16(20), 3508; https://doi.org/10.3390/nu16203508 - 16 Oct 2024
Abstract
Background: Metabolic syndrome (MetS) is a set of conditions associated with an increased cardiovascular risk. Several serum fatty acids (FAs) seem to play an essential role in the development of cardiometabolic diseases and mortality. Thus, it is imperative to explore the impact of [...] Read more.
Background: Metabolic syndrome (MetS) is a set of conditions associated with an increased cardiovascular risk. Several serum fatty acids (FAs) seem to play an essential role in the development of cardiometabolic diseases and mortality. Thus, it is imperative to explore the impact of FAs on MetS parameters, using an early MetS screening tool such as MetScore, which is readily available in clinical practice. Aim: The aim of this study was to assess the potential correlation between serum FAs and cardiovascular risk using a MetScore. Methods: This cross-sectional study involved 41 women with severe obesity. The MetScore was calculated, and participants were categorized into high- and low-cardiovascular-risk groups based on the median MetScore value. Gas chromatography was used to quantify serum FAs. Generalized Linear Models were used to compare group means. The association was assessed through simple logistic regression, and an adjusted logistic regression was conducted to validate the association between Metscore and serum FAs. Results: The high-cardiovascular-risk group exhibited elevated values of HOMA-IR, palmitic, oleic, cis-vaccenic, and monounsaturated fatty acids, as well as the SCD-18C, indicating a heightened cardiovascular risk. Conversely, HDL-c, QUICK, gamma-linolenic, and eicosatetraenoic fatty acids showed lower values compared to the low-risk group. Conclusions: Women with severe obesity and high cardiovascular risk have lower values of some omega-3 and omega-6 FAs, considered cardioprotective and anti-inflammatory, and have higher lipogenic activity and FAs, correlated with high cardiovascular risk. These findings emphasize the need to address lipid metabolism in this population as a therapeutic target to reduce cardiovascular risk. Future research should explore clinical interventions that modulate fatty acid metabolism to mitigate cardiometabolic complications. Full article
(This article belongs to the Section Nutrition in Women)
Show Figures

Figure 1

Figure 1
<p>Graphical illustration of the study design: stages of participant recruitment and data collection.</p>
Full article ">Figure 2
<p>Illustration of linoleic acid bioconversion pathway, eicosanoid synthesis, and cardiovascular risk. Green arrows: anti-inflammatory pathways; Red arrow: inflammatory pathways.</p>
Full article ">Figure 3
<p>The mechanism by which PUFA [n3] decreases triacylglycerol biosynthesis.</p>
Full article ">
29 pages, 7405 KiB  
Article
Immunological Strategies in Gastric Cancer: How Toll-like Receptors 2, -3, -4, and -9 on Monocytes and Dendritic Cells Depend on Patient Factors?
by Marek Kos, Krzysztof Bojarski, Paulina Mertowska, Sebastian Mertowski, Piotr Tomaka, Łukasz Dziki and Ewelina Grywalska
Cells 2024, 13(20), 1708; https://doi.org/10.3390/cells13201708 - 16 Oct 2024
Abstract
(1) Introduction: Toll-like receptors (TLRs) are key in immune response by recognizing pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs). In gastric cancer (GC), TLR2, TLR3, TLR4, and TLR9 are crucial for modulating immune response and tumor progression. (2) Objective: This study [...] Read more.
(1) Introduction: Toll-like receptors (TLRs) are key in immune response by recognizing pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs). In gastric cancer (GC), TLR2, TLR3, TLR4, and TLR9 are crucial for modulating immune response and tumor progression. (2) Objective: This study aimed to assess the percentage of dendritic cells and monocytes expressing TLR2, TLR3, TLR4, and TLR9, along with the concentration of their soluble forms in the serum of GC patients compared to healthy volunteers. Factors such as disease stage, tumor type, age, and gender were also analyzed. (3) Materials and Methods: Blood samples from newly diagnosed GC patients and healthy controls were immunophenotyped using flow cytometry to assess TLR expression on dendritic cell subpopulations and monocytes. Serum-soluble TLRs were measured by ELISA. Statistical analysis considered clinical variables such as tumor type, stage, age, and gender. (4) Results: TLR expression was significantly higher in GC patients, except for TLR3 on classical monocytes. Soluble forms of all TLRs were elevated in GC patients, with significant differences based on disease stage but not tumor type, except for serum TLR2, TLR4, and TLR9. (5) Conclusions: Elevated TLR expression and soluble TLR levels in GC patients suggest a role in tumor pathogenesis and progression, offering potential biomarkers and therapeutic targets. Full article
Show Figures

Figure 1

Figure 1
<p>Graphical representation of the characteristics of GC patients and healthy volunteers included in the study. (<b>A</b>) illustrates the distribution of GC patients by disease stage at diagnosis; (<b>B</b>) shows the division of patients by histopathological type of GC: intestinal type and diffuse type; (<b>C</b>) presents the gender distribution in both the GC patient group and the healthy control group; and (<b>D</b>) shows the age diversity of the recruited GC patients and healthy volunteers, showing the full age range of the study subjects. Abbreviations: GC, gastric cancer; HV, healthy volunteers.</p>
Full article ">Figure 2
<p>Comparison of the obtained results of the assessment of the percentage of the studied TLRs on dendritic cell subpopulations between patients in the individual stages of the disease. (<b>A</b>–<b>D</b>) Analysis of the percentage of TLR-2, TLR-3, TLR-4, and TLR-9 on BDCA-1 dendritic cells; (<b>E</b>–<b>H</b>) Analysis of the percentage of TLR-2, TLR-3, TLR-4, and TLR-9 on BDCA-2 dendritic cells. Statistically significant differences between the individual stages are marked with letters. To facilitate interpretation, the appropriate GC stages are marked with individual colors (green—stage I; blue—stage II; purple—stage III; pink—stage IV).</p>
Full article ">Figure 3
<p>Comparison of the obtained results of the concentration of soluble forms of the studied TLRs in serum between patients in individual stages of the disease. (<b>A</b>–<b>D</b>) Analysis of serum concentrations of sTLR-2, sTLR-3, sTLR-4, and sTLR-9. Statistically significant differences between individual stages are marked with letters. To facilitate interpretation, the appropriate GC stages are marked with individual colors (green—stage I; blue—stage II; purple—stage III; pink—stage IV).</p>
Full article ">Figure 4
<p>Comparison of the obtained results of the assessment of the percentage of the studied TLRs on monocyte subpopulations between patients in the individual stages of the disease. (<b>A</b>–<b>D</b>) Analysis of the percentage of TLR-2, TLR-3, TLR-4, and TLR-9 on classical monocytes; (<b>E</b>–<b>H</b>) Analysis of the percentage of TLR-2, TLR-3, TLR-4, and TLR-9 on intermediate monocytes; (<b>I</b>–<b>L</b>) Analysis of the percentage of TLR-2, TLR-3, TLR-4, and TLR-9 on non-classical monocytes. Statistically significant differences between individual stages are marked with letters. To facilitate interpretation, the appropriate GC stages are marked with individual colors (green—stage I; blue—stage II; purple—stage III; pink—stage IV).</p>
Full article ">Figure 5
<p>Comparison of the obtained results of the assessment of the percentage of the studied TLRs on dendritic cell subpopulations between patients depending on the patient’s gender. (<b>A</b>–<b>D</b>) Analysis of the percentage of TLR-2, TLR-3, TLR-4, and TLR-9 on BDCA-1 DCs; (<b>E</b>–H) Analysis of the percentage of TLR-2, TLR-3, TLR-4, and TLR-9 on BDCA-2 dendritic cells. Statistically significant differences between individual stages are marked with letters. To facilitate interpretation, the respective sexes are marked with individual colors (pink—women with GC; navy blue—men with GC; purple—women HV; light blue—men HV).</p>
Full article ">Figure 6
<p>Comparison of the obtained results of the assessment of the percentage of the studied TLRs on monocyte subpopulations between patients depending on the patient’s gender. (<b>A</b>–<b>D</b>) Analysis of the percentage of TLR-2, TLR-3, TLR-4, and TLR-9 on classical monocytes; (<b>E</b>–H Analysis of the percentage of TLR-2, TLR-3, TLR-4, and TLR-9 on intermediate monocytes; (<b>I</b>–<b>L</b>) Analysis of the percentage of TLR-2, TLR-3, TLR-4, and TLR-9 on non-classical monocytes. Statistically significant differences between individual stages are marked with letters. To facilitate interpretation, the respective genders are marked with individual colors (pink—women with GC; navy blue—men with GC; purple—women HV; light blue—men HV).</p>
Full article ">Figure 7
<p>Comparison of the obtained results of the concentration of soluble forms of the studied TLRs in serum between patients, taking into account differences in gender. (<b>A</b>–<b>D</b>) Analysis of serum concentrations of sTLR-2, sTLR-3, sTLR-4, and sTLR-9. Statistically significant differences between individual stages are marked with letters. To facilitate interpretation, individual colors indicate the appropriate genders (pink—women with GC; navy blue—men with GC; purple—women HV; light blue—men HV).</p>
Full article ">Figure 8
<p>Schematic representation of the Spearman rank correlation of the studied parameters in patients with newly diagnosed GC. For ease of interpretation, negative correlations are marked in red, while positive correlations are marked in blue. The intensity of the coloring of individual pairs indicates the strength of correlations.</p>
Full article ">Figure 9
<p>Graphical representation of selected ROC curves depending on the disease stage in GC patients. (<b>A</b>–<b>D</b>) ROC curves presenting a comparison of the sensitivity and specificity of the tested TLRs on BDCA-1; (<b>E</b>–<b>H</b>) ROC curves presenting a comparison of the sensitivity and specificity of the tested concentrations of soluble forms of TLRs in the serum of patients.</p>
Full article ">Figure 10
<p>Graphical representation of selected ROC curves depending on the sex of recruited patients. (<b>A</b>–<b>D</b>) ROC curves presenting a comparison of sensitivity and specificity of the tested TLRs on BDCA-1; (<b>E</b>–<b>H</b>) ROC curves presenting a comparison of sensitivity and specificity of the tested concentrations of soluble forms of TLRs in the serum of patients.</p>
Full article ">Figure 11
<p>Graphical representation of selected ROC curves depending on the age of recruited patients. (<b>A</b>–<b>D</b>) ROC curves presenting a comparison of sensitivity and specificity of the tested TLRs on BDCA-1; (<b>E</b>–<b>H</b>) ROC curves presenting a comparison of sensitivity and specificity of the tested concentrations of soluble forms of TLRs in the serum of patients.</p>
Full article ">
16 pages, 484 KiB  
Article
Fatty Acid β-Oxidation May Be Associated with the Erythropoietin Resistance Index in Stable Patients Undergoing Haemodialysis
by Shuhei Kidoguchi, Kunio Torii, Toshiharu Okada, Tomoko Yamano, Nanami Iwamura, Kyoko Miyagi, Tadashi Toyama, Masayuki Iwano, Ryoichi Miyazaki, Yosuke Shigematsu and Hideki Kimura
Diagnostics 2024, 14(20), 2295; https://doi.org/10.3390/diagnostics14202295 (registering DOI) - 16 Oct 2024
Viewed by 19
Abstract
Background/Objectives: Lipid metabolism and adiponectin modulate erythropoiesis in vitro and in general population studies and may also affect responsiveness to erythropoietin in patients undergoing haemodialysis (HD). However, little is known about the impact of lipid-associated biomarkers on reticulocyte production and erythropoietin resistance index [...] Read more.
Background/Objectives: Lipid metabolism and adiponectin modulate erythropoiesis in vitro and in general population studies and may also affect responsiveness to erythropoietin in patients undergoing haemodialysis (HD). However, little is known about the impact of lipid-associated biomarkers on reticulocyte production and erythropoietin resistance index (ERI) in patients undergoing HD. Therefore, we aimed to investigate their impacts in 167 stable patients undergoing HD. Methods: Pre-dialysis blood samples were collected and analysed for reticulocyte counts and serum lipid profiles by routine analyses and serum carnitine profiles (C0–C18) by LC-MS/MS. ERI was calculated as erythropoietin dose/kg/week normalized for haemoglobin levels. Results: The independent positive determinants of reticulocyte count were log [Triglyceride (TG)] and logC18:1. A large proportion of longer-chain acylcarnitines was positively correlated with reticulocyte counts, possibly resulting from the accumulation of acylcarnitines in mitochondria undergoing fateful exocytosis from reticulocytes. These results indicate a possible association between reticulocyte formation and reduced β-oxidation, which occurs during the peripheral phase of erythroblast enucleation. Total cholesterol (TC) and log [C2/(C16 + C18:1)] as a putative marker of β-oxidation efficiency were negative independent determinants of ERI. Moreover, acyl chain length had a significantly positive impact on the correlation coefficients of individual acylcarnitines with ERI, suggesting that enhanced β-oxidation may be associated with reduced ERI. Finally, adiponectin had no independent association with reticulocyte counts or ERI despite its negative association with HDL-C levels. Conclusions: Enhanced fatty acid β-oxidation and higher TC levels may be associated with lower ERI, whereas higher TG levels and longer acylcarnitines may be related to the latest production of reticulocytes in stable patients undergoing HD. Full article
Show Figures

Figure 1

Figure 1
<p>Scatter plots with a trend line between acylcarnitine chain length and partial correlation coefficients between each acylcarnitine and ERI show the results of the regression analysis. The partial correlation coefficients for ERI were adjusted for age, sex, and log (HD vintage).</p>
Full article ">
17 pages, 2192 KiB  
Article
Metabolite, Biochemical, and Dietary Intake Alterations Associated with Lifestyle Interventions in Obese and Overweight Malaysian Women
by Fatin Saparuddin, Mohd Naeem Mohd Nawi, Liyana Ahmad Zamri, Fazliana Mansor, Mohd Fairulnizal Md Noh, Mohd Azahadi Omar, Nur Shahida Abdul Aziz, Norasyikin A. Wahab, Ahmed Mediani, Nor Fadilah Rajab and Razinah Sharif
Nutrients 2024, 16(20), 3501; https://doi.org/10.3390/nu16203501 (registering DOI) - 16 Oct 2024
Viewed by 31
Abstract
Differences in metabolic regulation among obesity phenotypes, specifically metabolically healthy obese (MHO) and metabolically unhealthy obese (MUO) women, may lead to varied responses to interventions, which could be elucidated through metabolomics. Therefore, this study aims to investigate the differences in metabolite profiles between [...] Read more.
Differences in metabolic regulation among obesity phenotypes, specifically metabolically healthy obese (MHO) and metabolically unhealthy obese (MUO) women, may lead to varied responses to interventions, which could be elucidated through metabolomics. Therefore, this study aims to investigate the differences in metabolite profiles between MHO and MUO women and the changes following a lifestyle intervention. Serum samples from 36 MHO and 34 MUO women who participated in a lifestyle intervention for weight loss were analysed using untargeted proton nuclear magnetic resonance spectroscopy (1H NMR) at baseline and 6 months post-intervention. Anthropometric, clinical, and dietary intake parameters were assessed at both time points. Both groups showed differential metabolite profiles at baseline and after six months. Seven metabolites, including trimethylamine-N-oxide (TMAO), arginine, ribose, aspartate, carnitine, choline, and tyrosine, significantly changed between groups post-intervention, which all showed a decreasing pattern in MHO. Significant reductions in body weight and body mass index (BMI) in the MUO correlated with changes in the carnitine and tyrosine levels. In conclusion, metabolite profiles differed significantly between MHO and MUO women before and after a lifestyle intervention. The changes in carnitine and tyrosine levels in MUO were correlated with weight loss, suggesting potential targets for therapeutic intervention. Full article
(This article belongs to the Section Nutrition in Women)
Show Figures

Figure 1

Figure 1
<p>Summary of the lifestyle intervention programme.</p>
Full article ">Figure 2
<p>Metabolites that significantly changed between MHO and MUO following intervention.</p>
Full article ">Figure 3
<p>Metabolic pathways affected at sixth month.</p>
Full article ">Figure 4
<p>Heatmap of correlation between the significantly changed metabolites with body weight, BMI, WC, and systolic blood pressure in MUO. Correlation determined using Pearson correlation. Green indicates a positive correlation, while red indicates a negative correlation.</p>
Full article ">Figure 5
<p>Heatmap of correlation between the significantly changed metabolites with changes in anthropometry, clinical, and biochemical variables. Correlation determined using Pearson correlation analysis in both groups combined. Blue indicates a positive correlation, while red indicates a negative correlation.</p>
Full article ">
11 pages, 6168 KiB  
Article
Probiotic Enterococcus Faecium Attenuated Atherosclerosis by Improving SCFAs Associated with Gut Microbiota in ApoE−/− Mice
by Yuan Zhu, Chao Yin and Yeqi Wang
Bioengineering 2024, 11(10), 1033; https://doi.org/10.3390/bioengineering11101033 (registering DOI) - 16 Oct 2024
Viewed by 99
Abstract
Atherosclerosis, as the main root cause, makes cardiovascular diseases (CVDs) a substantial worldwide health concern. Inflammation and disrupted cholesterol metabolism are the primary clinical risk elements contributing to the onset of atherosclerosis. Few works exist on the improvement effect of gut microbiota on [...] Read more.
Atherosclerosis, as the main root cause, makes cardiovascular diseases (CVDs) a substantial worldwide health concern. Inflammation and disrupted cholesterol metabolism are the primary clinical risk elements contributing to the onset of atherosclerosis. Few works exist on the improvement effect of gut microbiota on atherosclerosis. One specific probiotic strain, Enterococcus faecium NCIMB11508, has shown promise in mitigating inflammation. Consequently, it is critical to investigate its potential in reducing the progression of atherosclerosis. In our study, we administered E. faecium NCIMB11508 orally to ApoE−/− mice, resulting in a decrease in the formation of atherosclerotic lesions. Additionally, it demonstrated the ability to lower the inflammatory factor levels both in the aorta and blood serum while maintaining the integrity of the small intestine against lipopolysaccharides. Moreover, E. faecium NCIMB11508 had a beneficial impact on the gut microbiota composition by increasing the levels of short-chain fatty acids (SCFAs), which in turn helped to reduce inflammation and protect the intestine. The probiotic E. faecium NCIMB11508, according to our research, has a definitive capacity to prevent atherosclerosis progression by beneficially altering the SCFA composition in the gut microbiota of ApoE−/− mice. Full article
(This article belongs to the Section Biochemical Engineering)
Show Figures

Figure 1

Figure 1
<p>(<b>A</b>) Representative ApoE<sup>−/−</sup> mice’s aortic arches and thoracic aorta were examined for white plaques using a stereomicroscope (SM). (<b>B</b>) Oil red O staining highlights plaques on the aortic roots. (<b>C</b>) Quantitative findings of atherosclerotic plaque regions in the aortic roots. CON, normal chow; HFD, high-fat diet plus PBS; EF, high-fat diet plus <span class="html-italic">E. faecium</span> NCIMB11508. The information is displayed as the average ± SD, with a sample size of 6, and * <span class="html-italic">p</span> &lt; 0.05; ** <span class="html-italic">p</span> &lt; 0.01.</p>
Full article ">Figure 2
<p>(<b>A</b>) Atherosclerotic lesions were detected with antibodies against CD68 and visualized by immunohistochemistry. Representative images from each group are shown. The area stained positively by CD68 (<b>B</b>) was determined as a percentage of the overall lesion area. The quantification of F4/80 (<b>C</b>), MCP-1 (<b>D</b>), and TNF-<span class="html-italic">α</span> (<b>E</b>) mRNA expression was performed in the aorta. The serum levels of IL-6 (<b>F</b>), IL-1<span class="html-italic">β</span> (<b>G</b>), and TNF-<span class="html-italic">α</span> (<b>H</b>) were quantified using ELISA.CON, normal chow; HFD, high-fat diet plus PBS; EF, high-fat diet plus <span class="html-italic">E. faecium</span> NCIMB11508. <span class="html-italic">E. faecium</span> NCIMB11508, 10<sup>9</sup> CFU/day, 12 weeks. The information is displayed as the average ± SD, with a sample size of 6, and * <span class="html-italic">p</span> &lt; 0.05; ** <span class="html-italic">p</span> &lt; 0.01.</p>
Full article ">Figure 3
<p>Immunofluorescent staining was used to visualize ZO-1 in the intestinal villi. (<b>B</b>) Images from (<b>A</b>) underwent a numerical evaluation. (<b>C</b>) Lipopolysaccharide content in the serum. The quantification of occludin and ZO-1 proteins’ mRNA expression was carried out in the duodenum (<b>D</b>), jejunum (<b>E</b>), and ileum (<b>F</b>). Representative images from each group are shown. CON, normal chow; HFD, high-fat diet plus PBS; EF, high-fat diet plus <span class="html-italic">E. faecium</span> NCIMB11508. The information is displayed as the average ± SD, with a sample size of 6, and * <span class="html-italic">p</span> &lt; 0.05; ** <span class="html-italic">p</span> &lt; 0.01.</p>
Full article ">Figure 4
<p>(<b>A</b>–<b>D</b>) Chemical imaging map of SCFAs through high-performance liquid chromatography of the control and three samples. (<b>A</b>) the standard/control sample. (<b>B</b>) CON group. (<b>C</b>) HFD group. (<b>D</b>) EF group. (<b>E</b>) Acetic acid. (<b>F</b>) propionic acid. (<b>G</b>) butyric acid. CON, normal chow; HFD, high-fat diet plus PBS; EF, high-fat diet plus <span class="html-italic">E. faecium</span> NCIMB11508. The information is displayed as the average ± SD, with a sample size of 3, and ** <span class="html-italic">p</span> &lt; 0.01.</p>
Full article ">Figure 5
<p>(<b>A</b>) The abundance of Akkermansia. (<b>B</b>) The abundance of Roseburia. (<b>C</b>) The abundance of Blautia. (<b>D</b>) The abundance of Faecalibaculum. (<b>E</b>) The abundance of Ruminococcus. CON, normal chow; HFD, high-fat diet plus PBS; EF, high-fat diet plus <span class="html-italic">E. faecium</span> NCIMB11508. The information is displayed as the average ± SD, with a sample size of 6, and * <span class="html-italic">p</span> &lt; 0.05; ** <span class="html-italic">p</span> &lt; 0.01.</p>
Full article ">
31 pages, 1150 KiB  
Review
How Do ROS Induce NETosis? Oxidative DNA Damage, DNA Repair, and Chromatin Decondensation
by Dhia Azzouz and Nades Palaniyar
Biomolecules 2024, 14(10), 1307; https://doi.org/10.3390/biom14101307 (registering DOI) - 16 Oct 2024
Viewed by 116
Abstract
Neutrophil extracellular traps (NETs) are intricate, DNA-based, web-like structures adorned with cytotoxic proteins. They play a crucial role in antimicrobial defense but are also implicated in autoimmune diseases and tissue injury. The process of NET formation, known as NETosis, is a regulated cell [...] Read more.
Neutrophil extracellular traps (NETs) are intricate, DNA-based, web-like structures adorned with cytotoxic proteins. They play a crucial role in antimicrobial defense but are also implicated in autoimmune diseases and tissue injury. The process of NET formation, known as NETosis, is a regulated cell death mechanism that involves the release of these structures and is unique to neutrophils. NETosis is heavily dependent on the production of reactive oxygen species (ROS), which can be generated either through NADPH oxidase (NOX) or mitochondrial pathways, leading to NOX-dependent or NOX-independent NETosis, respectively. Recent research has revealed an intricate interplay between ROS production, DNA repair, and NET formation in different contexts. UV radiation can trigger a combined process of NETosis and apoptosis, known as apoNETosis, driven by mitochondrial ROS and DNA repair. Similarly, in calcium ionophore-induced NETosis, both ROS and DNA repair are key components, but only play a partial role. In the case of bacterial infections, the early stages of DNA repair are pivotal. Interestingly, in serum-free conditions, spontaneous NETosis occurs through NOX-derived ROS, with early-stage DNA repair inhibition halting the process, while late-stage inhibition increases it. The intricate balance between DNA repair processes and ROS production appears to be a critical factor in regulating NET formation, with different pathways being activated depending on the nature of the stimulus. These findings not only deepen our understanding of the mechanisms behind NETosis but also suggest potential therapeutic targets for conditions where NETs contribute to disease pathology. Full article
(This article belongs to the Section Cellular Biochemistry)
Show Figures

Figure 1

Figure 1
<p>Summary figure detailing the mechanisms involved in NOX-dependent NETosis (green arrows) and NOX-independent NETosis with (red arrows) and without (purple arrows) peptidylarginine deiminase 4 (PAD4) activation. Following the initiation of NETosis, the production of ROS occurs, which can originate from either NOX or mitochondria. ROS induce oxidative DNA damage. Kinase activation, in turn, activates transcription factors. Transcription coupled with DNA repair is then initiated, leading to the unwinding and nicking of DNA. In the context of calcium ionophore-induced NETosis, PAD4 results in the citrullination of histones. Ultimately, these processes result in the release of DNA extracellularly as NETs.</p>
Full article ">
43 pages, 1049 KiB  
Review
A Scoping Review on Hepatoprotective Mechanism of Herbal Preparations through Gut Microbiota Modulation
by Chin Long Poo, Mei Siu Lau, Nur Liana Md Nasir, Nik Aina Syazana Nik Zainuddin, Mohd Rahimi Ashraf Abd Rahman, Siti Khadijah Mustapha Kamal, Norizah Awang and Hussin Muhammad
Curr. Issues Mol. Biol. 2024, 46(10), 11460-11502; https://doi.org/10.3390/cimb46100682 (registering DOI) - 16 Oct 2024
Viewed by 104
Abstract
Liver diseases cause millions of deaths globally. Current treatments are often limited in effectiveness and availability, driving the search for alternatives. Herbal preparations offer potential hepatoprotective properties. Disrupted gut microbiota is linked to liver disorders. This scoping review aims to explore the effects [...] Read more.
Liver diseases cause millions of deaths globally. Current treatments are often limited in effectiveness and availability, driving the search for alternatives. Herbal preparations offer potential hepatoprotective properties. Disrupted gut microbiota is linked to liver disorders. This scoping review aims to explore the effects of herbal preparations on hepatoprotective mechanisms, particularly in the context of non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), and hepatic steatosis, with a focus on gut microbiota modulation. A systematic search was performed using predetermined keywords in four electronic databases (PubMed, Scopus, EMBASE, and Web of Science). A total of 55 studies were included for descriptive analysis, covering study characteristics such as disease model, dietary model, animal model, intervention details, comparators, and study outcomes. The findings of this review suggest that the hepatoprotective effects of herbal preparations are closely related to their interactions with the gut microbiota. The hepatoprotective mechanisms of herbal preparations are shown through their effects on the gut microbiota composition, intestinal barrier, and microbial metabolites, which resulted in decreased serum levels of liver enzymes and lipids, improved liver pathology, inhibition of hepatic fatty acid accumulation, suppression of inflammation and oxidative stress, reduced insulin resistance, and altered bile acid metabolism. Full article
(This article belongs to the Special Issue Advances in Molecular Biology Methods in Hepatology Research)
Show Figures

Figure 1

Figure 1
<p>Preferred reporting items for systematic review and meta-analysis (PRISMA) flow chart of included studies.</p>
Full article ">
21 pages, 949 KiB  
Review
Prognostic Role of PSMA-Targeted Imaging in Metastatic Castration-Resistant Prostate Cancer: An Overview
by Matteo Caracciolo, Angelo Castello, Massimo Castellani, Mirco Bartolomei and Egesta Lopci
Biomedicines 2024, 12(10), 2355; https://doi.org/10.3390/biomedicines12102355 (registering DOI) - 16 Oct 2024
Viewed by 134
Abstract
Objectives: Prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) has gained a primary role in prostate cancer (PCa) imaging, overcoming conventional imaging and prostate-specific antigen (PSA) serum levels, and has recently emerged as a promising technique for monitoring therapy response in metastatic [...] Read more.
Objectives: Prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) has gained a primary role in prostate cancer (PCa) imaging, overcoming conventional imaging and prostate-specific antigen (PSA) serum levels, and has recently emerged as a promising technique for monitoring therapy response in metastatic castration-resistant prostate cancer (mCRPC) patients treated with novel hormonal therapy, taxanes, and radioligand therapy (RLT). In this review, we aim to provide an overview of the most relevant aspects under study and future prospects related to the prognostic role of PSMA PET/CT in mCRPC. Methods: A systematic literature search was performed in the following databases: MEDLINE, PubMed, and EMBASE databases. The study focused exclusively on English-language studies, excluding papers not pertinent to the topic. Results: PSMA PET imaging offers a higher sensitivity and specificity than conventional imaging and provides accurate staging and efficient diagnosis of distant metastases. The data presented herein highlight the usefulness of PET in risk stratification, with a prognostic potential that can have a significant impact on clinical practice. Several prospective trials are ongoing and will shortly provide more evidence supporting the prognostic potential of PET PSMA data in this clinical scenario. Conclusions: Current evidence proves the prognostic role of PSMA PET/CT in different settings, with raising relevance also in the context of mCRPC. Full article
(This article belongs to the Section Cancer Biology and Oncology)
Show Figures

Figure 1

Figure 1
<p>In the present multipanel image, we provide the correlation between PSMA tumor volume (PSMA-TV) expressed in quartiles and overall survival, expressed in months (mo.). Panel (<b>a</b>) depicts the boxplots of the PSMA-TV measured in <span class="html-italic">ml</span> and the corresponding quartiles 1 to 4. Panel (<b>b</b>) provides separate overall survival curves related to each PSMA-TV quartile. Panels (<b>c</b>–<b>f</b>) provide some exemplary patients corresponding to the different quartiles together with blood levels of prostate-specific antigen (PSA). Reproduced from Seifert, R et al. [<a href="#B37-biomedicines-12-02355" class="html-bibr">37</a>], published under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a> (accessed on 19 September 2024).</p>
Full article ">
Back to TopTop